Helping Doctors identify Minimal Hepatic Encephalopathy Quickly & Efficiently in busy practices!
Gift HE patients an Early Reversal & an Improved Quality of Life
Schedule a Call ›
Conventional screening tools like PHES & etc are:
Tools like the Psychometric Hepatic Encephalopathy Score (PHES) are crucial for diagnosing and managing hepatic encephalopathy, enabling early detection and effective treatment.
Language & Literacy Dependent
Time Consuming & Subjective
Having Related Learning Effects
Requires Trained Staff
Screen COVERT Hepatic Encephalopathy pre-emptively,
Even before clinical symptoms manifest

Helping Doctors Detect Hepatic Encephalopathy Early!
Scientifically Validated No Language Dependency Precise & Quick No Learning EffectsObjectively assess MHE in your Busy OPD:
HepaBuddy Device:
High Accuracy
High Specificity
High Reproducibility
HepaBuddy Dashboard

Easily set up HepaBuddy @your OPD/ Hospital
Download Catalog ›Helping Doctors improve HE Management
Screen Patients to rule out MHE
- Detecting changes in CFF scores from last visit
- Compliance & Adherence to Prescription (Medicines, Diet & Advice)
- Check Treatment Effectiveness
- Adjust Medicine Dosage
- Adjust Diet
Assessing Therapy Efficacy
- Early Trigger Detection & Timely Intervention for:
- Non GI / Systemic Infections
- Dehydration, or Medication Side Effects
- Check for Extrahepatic Causes
- Electrolyte Imbalance
- Diuretic Overdose
- GI Bleeding
- Use of Unproven Alternative Therapies
HepaBuddy: Improving Compliance & Outcomes
Mass screening at Peripheral or Referral Centers
Patient waiting for Transplant
Hear from the Experts:
The device has been tested on 60+ patients and a control group at Global Hospitals, which helped identify patients in MHE even before clinical symptoms could manifest, allowing early action. It has profound potential in clinical and non-clinical markets such as drivers, heavy machinery operators, and other complex occupations. The patient version is especially exciting, as it's being studied in trials led at Nanavati.
Clinical Investigator — Nanavati trialHelping Doctors identify Minimal Hepatic Encephalopathy Quickly & Efficiently in busy practices!
Gift HE patients an Early Reversal & an Improved Quality of Life
Schedule a Call ›
Conventional screening tools like PHES & etc are:
Tools like the Psychometric Hepatic Encephalopathy Score (PHES) are crucial for diagnosing and managing hepatic encephalopathy, enabling early detection and effective treatment.
Language & Literacy Dependent
Time Consuming & Subjective
Having Related Learning Effects
Requires Trained Staff
Screen COVERT Hepatic Encephalopathy pre-emptively,
Even before clinical symptoms manifest

Helping Doctors Detect Hepatic Encephalopathy Early!
Scientifically Validated No Language Dependency Precise & Quick No Learning EffectsObjectively assess MHE in your Busy OPD:
HepaBuddy Device:
High Accuracy
High Specificity
High Reproducibility
HepaBuddy Dashboard

Easily set up HepaBuddy @your OPD/ Hospital
Download Catalog ›Helping Doctors improve HE Management
Screen Patients to rule out MHE
- Detecting changes in CFF scores from last visit
- Compliance & Adherence to Prescription (Medicines, Diet & Advice)
- Check Treatment Effectiveness
- Adjust Medicine Dosage
- Adjust Diet
Assessing Therapy Efficacy
- Early Trigger Detection & Timely Intervention for:
- Non GI / Systemic Infections
- Dehydration, or Medication Side Effects
- Check for Extrahepatic Causes
- Electrolyte Imbalance
- Diuretic Overdose
- GI Bleeding
- Use of Unproven Alternative Therapies
HepaBuddy: Improving Compliance & Outcomes
Mass screening at Peripheral or Referral Centers
Patient waiting for Transplant
Hear from the Experts:
The device has been tested on 60+ patients and a control group at Global Hospitals, which helped identify patients in MHE even before clinical symptoms could manifest, allowing early action. It has profound potential in clinical and non-clinical markets such as drivers, heavy machinery operators, and other complex occupations. The patient version is especially exciting, as it's being studied in trials led at Nanavati.
Clinical Investigator — Nanavati trial